text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000306536/2022

text: clinical

text: Baseline surveillance


status: PUBLIC

text: SARS-CoV-2: clinical or host-associated

tag: attribute

characteristic: BioSampleModel

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: pda|emily.smith@theiagen.com

characteristic: INSDC center alias

text: pda|emily.smith@theiagen.com

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: NCBI

characteristic: broker name

text: CDPH VBL

text: USA: California

text: Homo sapiens

characteristic: host

text: SARS-CoV-2/Human/USA/CA-CDPH-3000306538/2022

characteristic: isolate

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

characteristic: organism

text: Baseline surveillance

characteristic: title


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000306539/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000306540/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000306542/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000306543/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000306545/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000306546/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000306548/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000306556/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000306582/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000306585/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000306587/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000306642/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000306643/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000307419/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000307424/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000307433/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000307435/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000307436/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000307437/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000307438/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000308649/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000308701/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000308702/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000308810/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000308835/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000308853/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000308855/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000308856/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000308857/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000308858/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000308860/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000308861/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000308862/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000308865/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000308866/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000308867/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000308868/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000308911/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000308914/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000308916/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000308958/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000308960/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000309761/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000309764/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000309958/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000309963/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000310712/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000310713/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000310715/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000310716/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000310722/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000310724/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000311177/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000311443/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000311446/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000311447/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000311651/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000311653/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000311738/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000311744/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000312574/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000313003/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000313004/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000313025/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000313027/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000313030/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000313035/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000313038/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000313043/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000313436/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000313762/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000313764/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000314672/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000314941/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000315455/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000316175/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000316209/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000316329/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000316527/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000316532/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000316537/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000316538/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000316558/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000316619/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000317368/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000317396/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000317399/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000317462/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000317483/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000317487/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000317488/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000317503/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000317517/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000317521/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000317523/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000318069/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000318191/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000318255/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000318271/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000318381/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000318383/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000318393/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000318471/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000318503/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000318504/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000318506/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000318508/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000318603/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000318612/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000318627/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000318639/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000318717/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000318772/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000318774/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000318777/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000318860/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000318865/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000318866/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000318957/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000318959/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000318986/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000319374/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000319379/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000319383/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000319411/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000319520/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000319527/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000319667/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320071/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320078/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320113/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320156/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320163/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320175/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320183/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320189/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320210/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320213/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320248/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320249/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320283/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320284/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320342/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320345/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320348/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320349/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320351/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320398/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320401/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320412/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320413/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320425/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320444/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320628/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320632/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320729/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320730/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320954/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320990/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000320992/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000321012/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000321014/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000321016/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000321017/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000321656/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324077/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000324787/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000327967/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000328034/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000328040/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000328045/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000329293/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000329361/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000329362/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000329363/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000329926/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000330144/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000330196/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000330211/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000330214/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000330216/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000330218/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000330220/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000330229/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000330236/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000330241/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000330248/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000330277/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000335811/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000335814/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000335815/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337202/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337203/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337204/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337290/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337297/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337310/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337366/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337368/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337371/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337381/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337384/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337387/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337415/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337515/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337516/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337520/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337521/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337522/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337524/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337525/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337527/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337528/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337529/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337530/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337531/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337552/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337553/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337554/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337556/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337557/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337560/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337561/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337581/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337586/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337587/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337723/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337731/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000337752/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000338238/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000338251/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000338254/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000338999/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000339179/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000339180/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000339181/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000339205/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340141/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340142/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340143/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340145/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340148/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340153/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340159/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340182/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340225/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340228/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340233/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340236/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340237/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340251/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340256/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340261/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340273/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340286/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340287/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340289/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340369/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340373/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340544/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340895/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340929/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340930/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340933/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340934/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000340935/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000341471/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000341538/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000341757/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000341766/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000341768/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000341771/2022

text: clinical

text: Severe acute respiratory syndrome coronavirus 2

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000341777/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000342713/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000342860/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000342900/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000342901/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000344252/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000344253/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000344258/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000344353/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000344736/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000345015/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000345018/2022

text: clinical

text: Baseline surveillance


text: SARS-CoV-2: clinical or host-associated

text: pda|emily.smith@theiagen.com

text: pda|emily.smith@theiagen.com

text: public

text: NCBI

text: CDPH VBL

text: USA: California

text: Homo sapiens

text: SARS-CoV-2/Human/USA/CA-CDPH-3000345471/2022

text: clinical

text: Baseline surveillance


text: MIMARKS.survey

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

text: public

text: NCBI

text: 0-10 cm

characteristic: depth

text: Season: Dry; Country: Colombia; Transect & Position: A0

characteristic: description

characteristic: elev

text: Tropical Forest Biome

text: Forest

text: Soil

text: Colombia

text: 5.06 N 74.83 W

text: eukaryotic metagenome

text: DRY4: Incorporating seasonally and spatially dynamic ectomycorrhizal fungal communities strengthens predictions of soil biogeochemical cycling in neotropical dry forests


text: MIMARKS.survey

characteristic: BioSampleModel

characteristic: ENA-FIRST-PUBLIC

characteristic: ENA-LAST-UPDATE

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

text: public

text: NCBI

text: 0-10 cm

text: Season: Dry; Country: Colombia; Transect & Position: A5

text: Tropical Forest Biome

text: Forest

text: Soil

text: Colombia

text: 5.06 N 74.83 W

text: eukaryotic metagenome


text: MIMARKS.survey

characteristic: External Id

text: pda|kennedyp@umn.edu

characteristic: INSDC center alias

text: pda|kennedyp@umn.edu

characteristic: INSDC center name

text: public

text: NCBI

text: 0-10 cm

text: Season: Dry; Country: Colombia; Transect & Position: A10

text: Tropical Forest Biome

text: Forest

text: Soil

text: Colombia

text: 5.06 N 74.83 W

text: eukaryotic metagenome


text: MIMARKS.survey

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: NCBI

text: 0-10 cm

text: Season: Dry; Country: Colombia; Transect & Position: A15

text: Tropical Forest Biome

text: Forest

text: Soil

text: Colombia

text: 5.06 N 74.83 W

text: eukaryotic metagenome


text: MIMARKS.survey

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

text: public

characteristic: SRA accession

characteristic: Submitter Id

text: NCBI

characteristic: broker name

text: 0-10 cm

text: Season: Dry; Country: Colombia; Transect & Position: A20

text: Tropical Forest Biome

text: Forest

text: Soil

text: Colombia

text: 5.06 N 74.83 W

text: eukaryotic metagenome


text: MIMARKS.survey

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

text: public

text: NCBI

text: 0-10 cm

text: Season: Dry; Country: Colombia; Transect & Position: B0

text: Tropical Forest Biome

text: Forest

text: Soil

text: Colombia

text: 5.06 N 74.83 W

text: eukaryotic metagenome

characteristic: organism


text: MIMARKS.survey

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

text: public

text: NCBI

text: 0-10 cm

text: Season: Dry; Country: Colombia; Transect & Position: B5

text: Tropical Forest Biome

text: Forest

text: Soil

text: Colombia

text: 5.06 N 74.83 W

text: eukaryotic metagenome

characteristic: title


text: MIMARKS.survey

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

text: public

text: NCBI

text: 0-10 cm

characteristic: depth

text: Season: Dry; Country: Colombia; Transect & Position: B10

text: Tropical Forest Biome

text: Forest

text: Soil

text: Colombia

text: 5.06 N 74.83 W

text: eukaryotic metagenome


text: MIMARKS.survey

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

text: public

text: NCBI

text: 0-10 cm

text: Season: Dry; Country: Colombia; Transect & Position: B15

characteristic: description

text: Tropical Forest Biome

text: Forest

text: Soil

text: Colombia

text: 5.06 N 74.83 W

text: eukaryotic metagenome


text: MIMARKS.survey

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

text: public

text: NCBI

text: 0-10 cm

text: Season: Dry; Country: Colombia; Transect & Position: B20

characteristic: elev

text: Tropical Forest Biome

text: Forest

text: Soil

text: Colombia

text: 5.06 N 74.83 W

text: eukaryotic metagenome


text: MIMARKS.survey

characteristic: BioSampleModel

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

text: public

text: NCBI

text: 0-10 cm

text: Season: Dry; Country: Colombia; Transect & Position: C0

text: Tropical Forest Biome

text: Forest

text: Soil

text: Colombia

text: 5.06 N 74.83 W

text: eukaryotic metagenome


text: MIMARKS.survey

characteristic: ENA-FIRST-PUBLIC

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

text: public

text: NCBI

text: 0-10 cm

text: Season: Dry; Country: Colombia; Transect & Position: C5

text: Tropical Forest Biome

text: Forest

text: Soil

text: Colombia

text: 5.06 N 74.83 W

text: eukaryotic metagenome


text: MIMARKS.survey

characteristic: ENA-LAST-UPDATE

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

text: public

text: NCBI

text: 0-10 cm

text: Season: Dry; Country: Colombia; Transect & Position: C10

text: Tropical Forest Biome

text: Forest

text: Soil

text: Colombia

text: 5.06 N 74.83 W

text: eukaryotic metagenome


text: MIMARKS.survey

characteristic: External Id

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

text: public

text: NCBI

text: 0-10 cm

text: Season: Dry; Country: Colombia; Transect & Position: C15

text: Tropical Forest Biome

text: Forest

text: Soil

text: Colombia

text: 5.06 N 74.83 W

text: eukaryotic metagenome


text: MIMARKS.survey

text: pda|kennedyp@umn.edu

characteristic: INSDC center alias

text: pda|kennedyp@umn.edu

text: public

text: NCBI

text: 0-10 cm

text: Season: Dry; Country: Colombia; Transect & Position: C20

text: Tropical Forest Biome

text: Forest

text: Soil

text: Colombia

text: 5.06 N 74.83 W

text: eukaryotic metagenome


text: MIMARKS.survey

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

characteristic: INSDC center name

text: public

text: NCBI

text: 0-10 cm

text: Season: Dry; Country: Colombia; Transect & Position: D0

text: Tropical Forest Biome

text: Forest

text: Soil

text: Colombia

text: 5.06 N 74.83 W

text: eukaryotic metagenome


text: MIMARKS.survey

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

characteristic: INSDC first public

text: public

text: NCBI

text: 0-10 cm

text: Season: Dry; Country: Colombia; Transect & Position: D5

text: Tropical Forest Biome

text: Forest

text: Soil

text: Colombia

text: 5.06 N 74.83 W

text: eukaryotic metagenome


text: MIMARKS.survey

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

characteristic: INSDC last update

text: public

text: NCBI

text: 0-10 cm

text: Season: Dry; Country: Colombia; Transect & Position: D10

text: Tropical Forest Biome

text: Forest

text: Soil

text: Colombia

text: 5.06 N 74.83 W

text: eukaryotic metagenome

text: DRY4: Incorporating seasonally and spatially dynamic ectomycorrhizal fungal communities strengthens predictions of soil biogeochemical cycling in neotropical dry forests


text: MIMARKS.survey

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

text: public

characteristic: INSDC status

text: NCBI

text: 0-10 cm

text: Season: Dry; Country: Costa Rica; Transect & Position: D0

text: Tropical Forest Biome

text: Forest

text: Soil

text: Costa Rica

text: 10.72 N 85.59 W

text: eukaryotic metagenome


text: MIMARKS.survey

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

text: public

characteristic: SRA accession

text: NCBI

text: 0-10 cm

text: Season: Dry; Country: Costa Rica; Transect & Position: D5

text: Tropical Forest Biome

text: Forest

text: Soil

text: Costa Rica

text: 10.72 N 85.59 W

text: eukaryotic metagenome


text: MIMARKS.survey

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

text: public

characteristic: Submitter Id

text: NCBI

text: 0-10 cm

text: Season: Dry; Country: Costa Rica; Transect & Position: D10

text: Tropical Forest Biome

text: Forest

text: Soil

text: Costa Rica

text: 10.72 N 85.59 W

text: eukaryotic metagenome


text: MIMARKS.survey

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

text: public

text: NCBI

characteristic: broker name

text: 0-10 cm

text: Season: Dry; Country: Costa Rica; Transect & Position: D15

text: Tropical Forest Biome

text: Forest

text: Soil

text: Costa Rica

text: 10.72 N 85.59 W

text: eukaryotic metagenome


text: MIMARKS.survey

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

text: public

text: NCBI

text: 0-10 cm

text: Season: Dry; Country: Costa Rica; Transect & Position: D20

text: Tropical Forest Biome

text: Forest

text: Soil

text: Costa Rica

text: 10.72 N 85.59 W

text: eukaryotic metagenome

characteristic: organism


text: MIMARKS.survey

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

text: public

text: NCBI

text: 0-10 cm

text: Season: Dry; Country: Costa Rica; Transect & Position: E0

text: Tropical Forest Biome

text: Forest

text: Soil

text: Costa Rica

text: 10.72 N 85.59 W

text: eukaryotic metagenome

characteristic: title


text: MIMARKS.survey

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

text: public

text: NCBI

text: 0-10 cm

characteristic: depth

text: Season: Dry; Country: Costa Rica; Transect & Position: E5

text: Tropical Forest Biome

text: Forest

text: Soil

text: Costa Rica

text: 10.72 N 85.59 W

text: eukaryotic metagenome


text: MIMARKS.survey

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

text: public

text: NCBI

text: 0-10 cm

text: Season: Dry; Country: Costa Rica; Transect & Position: E10

characteristic: description

text: Tropical Forest Biome

text: Forest

text: Soil

text: Costa Rica

text: 10.72 N 85.59 W

text: eukaryotic metagenome


text: MIMARKS.survey

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

text: public

text: NCBI

text: 0-10 cm

text: Season: Dry; Country: Costa Rica; Transect & Position: E15

characteristic: elev

text: Tropical Forest Biome

text: Forest

text: Soil

text: Costa Rica

text: 10.72 N 85.59 W

text: eukaryotic metagenome


text: MIMARKS.survey

characteristic: BioSampleModel

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

text: public

text: NCBI

text: 0-10 cm

text: Season: Dry; Country: Costa Rica; Transect & Position: E20

text: Tropical Forest Biome

text: Forest

text: Soil

text: Costa Rica

text: 10.72 N 85.59 W

text: eukaryotic metagenome


text: MIMARKS.survey

characteristic: ENA-FIRST-PUBLIC

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

text: public

text: NCBI

text: 0-10 cm

text: Season: Dry; Country: Costa Rica; Transect & Position: I5

text: Tropical Forest Biome

text: Forest

text: Soil

text: Costa Rica

text: 10.72 N 85.59 W

text: eukaryotic metagenome


text: MIMARKS.survey

characteristic: ENA-LAST-UPDATE

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

text: public

text: NCBI

text: 0-10 cm

text: Season: Dry; Country: Costa Rica; Transect & Position: I10

text: Tropical Forest Biome

text: Forest

text: Soil

text: Costa Rica

text: 10.72 N 85.59 W

text: eukaryotic metagenome


text: MIMARKS.survey

characteristic: External Id

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

text: public

text: NCBI

text: 0-10 cm

text: Season: Dry; Country: Costa Rica; Transect & Position: I15

text: Tropical Forest Biome

text: Forest

text: Soil

text: Costa Rica

text: 10.72 N 85.59 W

text: eukaryotic metagenome


text: MIMARKS.survey

text: pda|kennedyp@umn.edu

characteristic: INSDC center alias

text: pda|kennedyp@umn.edu

text: public

text: NCBI

text: 0-10 cm

text: Season: Dry; Country: Costa Rica; Transect & Position: I20

text: Tropical Forest Biome

text: Forest

text: Soil

text: Costa Rica

text: 10.72 N 85.59 W

text: eukaryotic metagenome


text: MIMARKS.survey

text: pda|kennedyp@umn.edu

text: pda|kennedyp@umn.edu

characteristic: INSDC center name

text: public

text: NCBI

text: 0-10 cm

text: Season: Dry; Country: Costa Rica; Transect & Position: P0

text: Tropical Forest Biome

text: Forest

text: Soil

text: Costa Rica

text: 10.72 N 85.59 W

text: eukaryotic metagenome